Costa Mesa, California (PRWEB) January 17, 2013
WCCT Global, a contract research organization (CRO) supporting Phase I - IV biopharmaceutical and device development, today announced the successful enrollment of more than a third of the patients required for a national chronic Hepatitis B study with very stringent inclusion/exclusion criteria. Recruitment was scheduled to last for 8 months and WCCT Global was able to help the sponsor complete recruitment in 2 months. WCCT Global was similarly able to recruit and over-enroll Hepatitis C patients on 2 other studies in 2012. WCCT Global attributes these successes to their established participant database which has been built over the past 14 years and their cutting edge marketing and recruitment tactics for participants in clinical trials. In an industry where enrolling qualified participants over a pre-specified period of time; both an established database and our “proven” media recruitment strategy are required. WCCT Global is setting the industry standard for this capability. Talia Nikolao M.B.A., VP of Business Development says, “When discussing a new project’s recruitment needs with a sponsor, we scrutinize the critical details, and then immediately begin to design our recruitment strategy. I am thrilled that our focus on patient recruitment has allowed us to over-enroll in these important trials”
WCCT Global has an established cutting edge web based recruitment and marketing process which has become the main driver for the high success rate that has been achieved so consistently. WCCT Global is pioneering the way that contract research organizations are recruiting participants for clinical trials.
More about WCCT Global’s full service clinical program:
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
Click Here to learn about how WCCT Global can assist in your next clinical trial.